The Discounted Cash Flow (DCF) valuation of Pharmagreen Biotech Inc (PHBI) is 0.00 USD. With the latest stock price at 0.00 USD, the upside of Pharmagreen Biotech Inc based on DCF is -47.7%.
Based on the latest price of 0.00 USD and our DCF valuation, Pharmagreen Biotech Inc (PHBI) is a sell. selling PHBI stocks now will result in a potential gain of 47.7%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 5.8% | 5.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 0.00 - 0.00 | 0.00 |
| Upside | -66.7% - -19.2% | -47.7% |